Effects of splenic surgeries on lipidogram of rats;Efeitos de operações sobre o baço no lipidograma de ratas

Revista da Associacao Medica Brasileira

Volumn 52, Issue 1, 2006, Pages 56-59

  Petroianu, Andy ^a,b   Magalhães Veloso, Denny Fabrício ^a   Costa, Gustavo Rocha ^a   Alberti, Luiz Ronaldo ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE   (Brazil)

Author keywords

Cholesterol; Partial splenectomy; Spleen; Splenectomy; Splenic autoimplants; Triglycerides

Indexed keywords

EID: 33646772848     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0104-42302006000100024     Document Type: Article

References (29)

1. Schmidt HH, Wagner S, Manns M. The spleen as a storage pool in lipid metabolism. Am J Gastroenterol 1997; 92: 1072-2.
2. Fatouros M, Bourantas K, Bairaktari E, Elisaf M, Tsolas O, Cassioumis D. Role of the spleen in lipid metabolism. Br J Surg 1995; 82: 1675-7.
3. Goldfarb AW, Rachmilewitz EA, Eisenberg S. Abnormal low and high density lipoproteins in homozygous beta-thalassaemia. Br J Haematol 1991; 79: 481-6.
4. Asai K, Hayashi T, Kuzuya M, Funaki C, Naito M, Kuzuya F. Delayed clearance of beta-very low density lipoprotein after feeding cholesterol to splenectomized rabbits. Artery 1990; 18: 32-46.
5. Asai K, Kuzuya M, Naito M, Funaki C, Kuzuya F. Effects of splenectomy on serum lipids and experimental atherosclerosis. Angiology 1988; 39: 497-504.
6. Le NA, Gibson JC, Rubinstein A, Grabowski GA, Ginsberg HN. Abnormalities in lipoprotein metabolism in Gaucher type 1 disease. Metabolism 1988; 3: 240-5.
7. Aviram M, Brook JG, Tatarsky I, Levy Y, Carter A. Increased low-density lipoprotein levels after splenectomy: a role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am J Med Sci 1986; 291: 25-8.
8. Gilbert HS, Ginsberg H, Fargerstrom R, Brown WV. Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity. Am J Med 1981; 71: 595-602.
9. Bednarik T, Cajthamlova H. Serum proteins after splenectomy in dog, the rabbit and the rat. Physiol Bohemoslov 1968; 17: 249-52.
10. Viana MB, Oliveira BM, Oliveira MCLA. O Baço em doenças metabólicas. In: Petroianu A, editor. O Baço. 1 ed. São Paulo: CLR Baliero Editores; 2003, p. 197-205.
11. Constantopoulos A, Najar VA, Wisch JB, Necheles TH, Stolbach LL: Defective phagocytosis due to tuftsin deficiency in splenectomized subjects. Am J Dis Child 1973; 125: 663-5.
12. Petroianu A. Estudos experimentais sobre o baço. In: Petroianu A, editor. O Baço. 1 ed. São Paulo: CLR Baliero Editores; 2003, p.414-26.
13. Sugihara T, Yawata Y. Observations on plasma and red cell lipids in hereditary spherocytosis. Clin Chim Acta 1984; 137: 227-32.
14. Paulo DNS, Lázaro da Silva A. Lipídeos plasmáticos após esplenectomia total e parcial em cães. Rev Col Bras Cir 2001; 28: 264-70.
15. King JH. Studies in the pathology of the spleen. Arch Intern Med 1914; 14: 145-67.
16. Cooper JE. Ethics and laboratory animals. Vet Rec 1985; 116: 594-5.
17. a Pesquisa experimental. In: Petroianu A, editor. Ética, Moral e Deontologia Médicas. Rio de Janeiro: Guanabara Koogan; 2000, p. 185-90.
18. Petroianu A. Cirurgia do baço. In: Petroianu A, editor. Clínica Cirúrgica. Rio de Janeiro: Revinter; 2001, p.429-42.
19. Morris DH, Bullock FD. The importance of the spleen in resistance to infection. Ann Surg 1919; 70: 513-21.
20. Morgenstern L. Evolution of splenic surgery. Contemp Surg 1986; 29: 15-8.
21. Morgenstern L. Techniques of splenic conservation. Arch Surg 1979; 114: 449-54.
22. Traub A, Giebink GS, Smith C. Splenic reticuloendothelial function after splenectomy, spleen repair and spleen autotransplantation. N Engl J Med 1987; 317:1559-64.
23. Times W, Leemans R: Splenic autotransplantation and the immune system. Ann Surg 1992; 215: 256-60.
24. Albrecht RM, Schermer CR, Morris A. Nonoperative management of blunt splenic injuries: Factors influencing success in age >55 years. Am Surg 2002; 68: 227-31.
25. a Edição. Rio de Janeiro: Guanabara Koogan; 2001, p.1212-24.
26. th edition. United States: W.B.Saunders Company; 1998, p. 1099-153.
27. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease. Am J Cardiol 1992; 70: 733-7.
28. Gordon DJ, Rifkind BM. High-density lipoprotein. The clinical implications of recent studies. N Engl J Med 1989; 321: 1311-6.
29. Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994; 121: 641-7.